Skip to main content

Table 1 Basic data at first dose of IPTi

From: Therapeutic and prophylactic effect of intermittent preventive anti-malarial treatment in infants (IPTi) from Ghana and Gabon

 

Kumasi cohort

Lambaréné cohort

 

SP

Placebo

SP

Placebo

Participants, n

535

535

504

507

Age, mean days (sd)

90 (± 12)

89 (± 11)

96 (± 14)

97 (± 14)

Hb, mean g/dL (sd)

10.4 (± 1.4)a

10.3 (± 1.3)b

10.0 (± 1.2)c

9.8 (± 1.3)d

Anaemiae, %

2.1a

2.1b

0.9c

2.2d

Parasitaemia, geomean/μlf

681

779

790

1240

  1. sd, standard deviation, SP, sulphadoxine-pyrimethamine
  2. a n = 531
  3. b n = 534
  4. c n = 461
  5. d n = 458
  6. e Hb < 7.5 g/dL
  7. f in those parasitaemic